Browse by category

Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorisation of Wegovy 7.2 mg (once-weekly injectable semaglutide 7.2 mg) in a single-dose pen and Wegovy pill. Wegovy 7.2 mg is already available in the EU for adults with obesity, dosed as three injections of 2.4 mg, and is based on results from the STEP UP trial programme. In the STEP UP

Olympus Corporation has received FDA 510(k) clearance for the POWERSEAL Open Extended Jaw Sealer/Divider. This latest edition to the Olympus POWERSEAL advanced bipolar surgical energy portfolio supports clinical needs for precision, efficiency and control during surgery. POWERSEAL Open Extended Jaw Sealer/Divider The POWERSEAL Open Extended Jaw Sealer/Divider joins three 5mm devices in the POWERSEAL portfolio. These 5mm devices are offered in three jaw configurations, each av

Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for iREACH IRIS, a next-generation powered stapling platform designed to deliver Real-Time Firing Curve and up to 90° articulation during surgery. iREACH IRIS Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation Unlike conventional powered staplers that provide general firing feedback, iREACH IRIS Real-Time Firing Curve provides a continuous, location-specific force

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved an update to Novo Nordisk’s...

The FDA has approved Mounjaro (tirzepatide, Eli Lilly and Company) injection to improve blood sugar control in adults with type 2...